title: Nanostructured SERS-electrochemical biosensors for testing of anticancer drug interactions with DNA.
abstract: Widely used anti-cancer treatments involving chemotherapeutic drugs result in cancer cell damage due to their strong interaction with DNA. In this work, we have developed laboratory biosensors for screening chemotherapeutic drugs and to aid in the assessment of DNA modification/damage caused by these drugs. The sensors utilize surface-enhanced Raman scattering (SERS) spectroscopy and electrochemical methods to monitor sensory film modification and observe the drug-DNA reactivity. The self-assembled monolayer protected gold-disk electrode (AuDE) was coated with a reduced graphene oxide (rGO), decorated with plasmonic gold-coated Fe2Ni@Au magnetic nanoparticles functionalized with double-stranded DNA (dsDNA), a sequence of the breast cancer gene BRCA1. The nanobiosensors AuDE/SAM/rGO/Fe2Ni@Au/dsDNA were then subjected to the action of a model chemotherapeutic drug, doxorubicin (DOX), to assess the DNA modification and its dose dependence. The designed novel nanobiosensors offer SERS/electrochemical transduction, enabling chemically specific and highly sensitive analytical signals generation. The SERS measurements have corroborated the DOX intercalation into the DNA duplex whereas the electrochemical scans have indicated that the DNA modification by DOX proceeds in a concentration dependent manner, with limit of detection LOD=8 µg/mL (S/N=3), with semilog linearity over 3 orders of magnitude. These new biosensors are sensitive to agents that interact with DNA and facilitate the analysis of functional groups for determination of the binding mode. The proposed nanobiosensors can be applied in the first stage of the drug development for testing the interactions of new drugs with DNA before the drug efficacy can be assessed in more expensive testing in vitro and in vivo.
authors: Department of Chemistry, State University of New York at Potsdam, Potsdam, NY 13676, USA.
authors: Hoda
authors: H
authors: Ilkhani
authors: Department of Chemistry, State University of New York at Potsdam, Potsdam, NY 13676, USA.
authors: Taylor
authors: T
authors: Hughes
authors: Department of Chemistry, State University of New York at Binghamton, Binghamton, NY 13902, USA.
authors: Jing
authors: J
authors: Li
authors: Department of Chemistry, State University of New York at Binghamton, Binghamton, NY 13902, USA.
authors: Chuan Jian
authors: CJ
authors: Zhong
authors: Department of Chemistry, State University of New York at Potsdam, Potsdam, NY 13676, USA. Electronic address: hepelmr@potsdam.edu.
authors: Maria
authors: M
authors: Hepel
mesh_terms: D015374:Biosensing Techniques; D004247:DNA / Q000737:chemistry / Q000187:drug effects*; D004249:DNA Damage / Q000187:drug effects*; D004317:Doxorubicin / Q000737:chemistry / Q000494:pharmacology; D055664:Electrochemical Techniques; D006046:Gold / Q000737:chemistry; D006108:Graphite / Q000737:chemistry; D006801:Humans; D053768:Metal Nanoparticles / Q000737:chemistry; D009369:Neoplasms / Q000188:drug therapy; D013059:Spectrum Analysis, Raman
chemical_list: D006046:Gold; D006108:Graphite; D004317:Doxorubicin; D004247:DNA
keywords: Breast cancer; Chemotherapeutic drug screening; DNA biosensor; Doxorubicin; Genosensor; SERS/electrochemical biosensor